Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Prevention of Atopy and Asthma With House Dust Mite Sublingual Immunotherapy: 6-8 Years Follow up

NCT03763630 is registered in ClinicalTrials.gov with University of Southampton as lead sponsor.

NCT NCT03763630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03763630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Prevention of Atopy and Asthma With House Dust Mite Sublingual Immunotherapy: 6-8 Years Follow up
Lead sponsor
University of Southampton
Phase
Phase 2
Overall status
Completed
Start date
September 15, 2017
Completion date
January 15, 2019
Enrollment
263 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

allergy and immunology, asthma, immunotherapy